Variable | Additional details |
---|---|
Study inclusion/exclusion | If excluded, rationale provided |
Design and setting | |
Dates | Study duration |
N, number of groups, and dropout rates | |
Participant demographics | This will include baseline cognitive status and activity or fitness level, diagnosis, disease severity, co-morbidities, Apo-E status, age, sex, nationality and/or ethnicity, socioeconomic status, and education |
Included caregiver or caretaker | |
Recruitment approach | |
Adherence reported according to how intervention was recorded | For example, supervised, unsupervised, objective monitors, etc. |
Follow-up assessment | |
Outcomes | To include cognitive, emotional, functional, motor, physiological, social, or quality of life |
Reported challenges and conflicts | |
Bias assessment variables | To include randomization method, randomization concealment, blinding, method of reporting outcomes, missing information, and other relevant variables |
Outcome description | To include scale range; minimal detectable change; and/or minimal clinically important difference; incidence of dementia; time to conversion; changes in health, cognitive, or quality of life variables; and changes in dementia related biomarkers |
Other outcome factors | To include time to follow-up in study methodology, scale range, minimal detectable change, and/or minimal clinically important difference |
Results: included participant group sizes, summary of results | For example, means, SD, and statistical changes |
Physical activity/exercise treatment prescription data | |
Physical activity/exercise modality | For example, type, group, peer/coach, and additional motivators |
Treatment minutes/session | |
Treatment duration | Total number of weeks |
Supervised or unsupervised treatment paradigm | |
Harm or side effects | Drug or secondary health condition interaction |